Flunarizine: A possible adjuvant medication against soman poisoning?

Drug and Chemical Toxicology

Volumn 27, Issue 3, 2004, Pages 213-231

  Carpentier, Pierre ^a   Foquin, Annie ^a   Lallement, Guy ^a   Dorandeu, Fréderic ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

Atropine sulfate; Brain damage; Calcium channel blockers; Convulsions; Diazepam; Flunarizine; Lethality; Rat; Soman

Indexed keywords

ATROPINE; CALCIUM CHANNEL BLOCKING AGENT; DIAZEPAM; FLUNARIZINE; SOMAN;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; INTOXICATION; LETHALITY; MALE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ATROPINE; BRAIN; CALCIUM CHANNEL BLOCKERS; CHEMICAL WARFARE AGENTS; DIAZEPAM; DRUG THERAPY, COMBINATION; FLUNARIZINE; GABA MODULATORS; LETHAL DOSE 50; MALE; MUSCARINIC ANTAGONISTS; RATS; RATS, WISTAR; SEIZURES; SOMAN;

ANIMALIA;

EID: 4544312384     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.1081/DCT-120037503     Document Type: Article

References (48)

1. Baethmann, A., Jansen, M. (1986). Possible role of calcium entry blockers in brain protection. Eur. Neurol. 25(1):102-114.
2. Bebin, M., Bleck, T. P. (1994). New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol. Drugs 48:153-171.
3. Bodjarian, N., Carpentier, P., Blanchet, G., Baubichon, D., Lallement, G. (1993). Cholinergic activation of phosphoinositide metabolism during soman-induced seizures. NeuroReport 4:1191-1193.
4. Carpentier, P., Foquin-Tarricone, A., Bodjarian, N., Rondouin, G., Lerner Natoli, M., Kamenka, J. M., Blanchet, G., Denoyer, M., Lallement, G. (1994). Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology 15:837-851.
5. Carpentier, P., Foquin, A., Rondouin, G., Lerner Natoli, M., de Groot, D. M. G., Lallement, G. (2000). Effects of atropine sulphate on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neuropathology. Neurotoxicology 21:521-540.
6. Carpentier, P., Foquin, A., Kamenka, J. M., Rondouin, G., Lerner-Natoli, M., De Groot, D. MG., Lallement, G. (2001). Effects of thienylphencyclidine (TCP) on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neurotoxicity. Neurotoxicology 22:13-28.
7. - channel blockers. Eur. J. Pharmacol. 131:1-12.
8. Cousin, M. A., Nicholls, D. G., Pocock, J. M. (1993). Flunarizine inhibits both calcium-dependent and -independent release of glutamate from synaptosomes and cultured neurons. Brain Res. 606:227-236.
9. Czyrak, A., Mogilnicka, E., Maj, J. (1991). Some central pharmacological effects of the calcium channel antagonist flunarizine. J. Neural Transm., Gen. Sect. 83:179-188.
10. De Sarro, G., De Sarro, A., Federico, F., Meldrum, B. S. (1990). Anticonvulsant properties of some calcium antagonists on sound-induced seizures in genetically epilepsy prone rats. Gen. Pharmacol. 21:769-778.
11. Dobric, S., Milovanovic, S. R. (2000). The protective efficacy of calcium channel blockers in soman-poisoned rats. In: ASA ed. Third CB Medical Treatment Symposium ASA. Switzerland: Spiez, p. 49.
12. Dretchen, K. L., Bowles, A. M., Raines, A. (1986). Protection by phenytoin and calcium channel blocking agents against the toxicity of diisopropylfluorophosphate. Toxicol Appl Pharmacol. 83:584-589.
13. Gasior, M., Kaminski, R., Brudniak, T., Kleinrok, Z., Czuczwar, S. J. (1996). Influence of Nicardipine, Nimodipine and Flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice. J. Neural. Transm., Gen. Sect. 103:819-831.
14. Gasior, M., Borowicz, K., Kleinrok, Z., Starownik, R., Czuczwar, S. J. (1997). Anti-convulsant and adverse effects of MK-801, LY 235959, and GYKI 52466 in combination with Ca2|channel inhibitors in mice. Pharmacol. Biochem. Behav. 56:629-635.
15. Hamilton, M. G., Posavad, C. (1991). Alteration of calcium influx in rat cortical synaptosomes by soman. NeuroReport 2:273-276.
16. Hoskins, B., Liu, D. D., Ho, I. K. (1986). Acute effects of soman, sarin, and tabun on microsomal and cytosolic components of the calmodulin system in rat striatum. J. Neurochem. 46:265-269.
17. Hunter, A. J. (1997). Calcium antagonists: their role in neuroprotection. In: Green, A. R., Cross, A. J., eds. Neuroprotective Agents and Cerebral Ischaemia. San Francisco: Academic Press, pp. 95-108.
18. Karler, R. LD., Calder, S. A., Turkanis, S. A. (1991). Calcium channel blockers and excitatory amino acids. Brain Res. 551:331-333.
19. Karlsson, B. M., Waara, L. M., Fredriksson, S. A., Koskinen, L. OD. (1997). The effect of calcium antagonist nimodipine on the detoxification of soman in anaesthetized rabbits. J. Pharm. Pharmacol. 49:296-300.
20. Karlsson, B. M., Koch, M., Koskinen, L. O. D. (1998). Effects of soman in animals pretreated with nimodipine. In: 6th CBW protection symposium. Stockholm, Sweden: FOA.
21. Kauffman, F. C., Davis, L. H., Whittaker, M. (1987). Release of Intracellular Calcium: A Novel Action of Organophosphates. Baltimore: US Army Medical Defense Bioscience Review, pp. 115-122.
22. Lallement, G., Carpentier, P., Collet, A., Pernot-Marino, I., Baubichon, D., Blanchet, G. (1991a). Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res. 563:234-240.
23. Lallement, G., Carpentier, P., Collet, A., Pernot-Marino, I., Baubichon, D., Blanchet, G. (1991b). Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: An autoradiographic study. Neurotoxicology 12:655-664.
24. Lallement, G., Carpentier, P., Collet, A., Baubichon, D., Pernot-Marino, I., Blanchet, G. (1992). Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. Neurotoxicology 13:557-567.
25. Lallement, G., Pernot-Marino, I., Foquin-Tarricone, A., Baubichon, D., Piras, A., Blanchet, G., Carpentier, P. (1994). Antiepileptic effects of NBQX against soman-induced seizures. NeuroReport 5:425-428.
26. Lallement, G., Dorandeu, F., Filliat, P., Carpentier, P., Baille, V., Blanchet, G. (1998). Medical management of organophosphate-induced seizures. J. Physiol Paris 92:369-373.
27. Lallement, G., Baubichon, D., Clarencon, D., Galonnier, M., Peoch, M., Carpentier, P. (1999). Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman. Neurotoxicology 20:675-684.
28. 3H] soman in mice. Acta Pharm. Sin. 23:937-941.
29. Martin, L. J., Doebler, J. A., Shih, T. M., Anthony, A. (1985). Protective effect of diazepamepam pretreatment on soman-induced brain lesion formation. Brain Res. 325:287-289.
30. McDonald, R. L. (1991). Antiepileptic drug actions on neurotransmitter receptors and ion channels. In: Fisher, R. S., Coylem, J. T., eds. Neurotransmitters and Epilepsy. New York: Wiley-Liss Inc, pp. 231-245.
31. McDonough, J. H., Shih, T. M. (1997). Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 21:559-579.
32. McDonough, J. Jr., Jaax, N. K., Crowley, R. A., Mays, M. Z., Modrow, H. E. (1989). Atropine and/or diazepamepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 13:256-276.
33. Meyer, F. B., Anderson, R. E., Sundt, T. M. Jr., Sharbrough, F. W. (1986). Selective central nervous system calcium channel blockers a new class of anticonvulsant agents. Mayo Clin. Proc. 61:239-247.
34. O'Neill, S. K., Bolger, G. T. (1989). Anticonvulsant activity of MK-801 and nimodipine alone and in combination against pentylenetetrazole and strychnine. Pharmacol. Biochem. Behav. 32:595-600.
35. Overweg, J., Binnie, C. D. (1989). Flunarizine, a useful adjuvant for therapy-resistant epilepsy patients. In: Hartmann, A., Kuschinsky, W., eds. Cerebral Ischemia and Calcium. Berlin: Springer-Verlag, pp. 462-469.
36. - channels involved in neuronal cell death. Protection by flunarizine. Life Sci. 48:1881-1893.
37. Raines, A., Henderson, T. R., Dretchen, K. L. (1989). Effects of calcium channel blocking agents on neostigmine-induced fasciculations. Eur. J. Pharmacol. 173:11-17.
38. Serra, M., Dazzi, L., Caddeo, M., Floris, C., Biggio, G. (1999). Reversal by flunarizine of the decrease in hippocampal acetylcholine release in pentylenetetrazole-kindled rats. Biochem. Pharmacol. 58:145-149.
39. Shih, T. M., McDonough, J. H. (1996). Pharmacological Antagonism of Nerve Agent-induced Seizures. In: Proceedings of the 1996 Medical Defence Bioscience Review USAMRICD. Vol. 1. Maryland: Aberdeen Proving Ground, pp. 435-446.
40. Shih, T. M., Koviak, T. A., Capacio, B. R. (1991). Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci. Biobehav. Rev. 15:349-362.
41. (2-)-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine. Gen. Pharmacol. 22:1151-1154.
42. Starreveld, E., De Beukelaar, F., Wilson, A. F., McLean, D. R., Findlay, H. P. (1989). Double-blind cross-over placebo controlled study of flunarizine in patients with therapy resistant epilepsy. Can. J. Neurol. Sci. 16:187-190.
43. Sun, M. C., Chang, Z. G., Shau, M. Z., Huang, R. H., Chou, T. C. (1979). The mechanism of aging of phosphonylated acetylcholinesterase. Eur. J. Biochem. 100:527-530.
44. Taylor, P. (1985). Anticholinesterase agents. In: Gilman, A. G., Goodman, L. S., Rall, T. W., Murad, F., eds. The Pharmacological Basis of Therapeutics. New York: Macmillan, pp. 110-129.
45. Tytgat, J., Pauwels, P. J., Vereecke, J., Carmeliet, E. (1991). Flunarizine inhibits a high-threshold inactivating calcium channel (N-type) in isolated hippocampal neurons. Brain Res. 549:112-117.
46. Van Reempts, J., Haseldonckx, M., van Deuren, B., Wouters, L., Borgers, M. (1986). Structural damage of the ischemic brain: involvement of calcium and effects of postischemic treatment with calcium entry blockers. Drug Dev. Res. 8:387-395.
47. Wachtel, R. E. (1987). Effects of diltiazem and verapamil on responses to acetylcholine. Br. J. Pharmacol. 92:561-566.
48. Wauquier, A., Ashton, D., Glincke, G., Fransen, J., Gillardon, J. M., Janssen, P. A. J. (1986). Anticonvulsant profile of flunarizine. Drug Dev. Res. 7:49-60.